Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxidectin alone and in combination for Trichuris trichiura infection
ISRCTN20398469Phase 2Completed
- Sponsor
- Swiss Tropical and Public Health Institute
- Start
- Mar 2017
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of moxidectin, tribendimidine, albendazole and oxantel in trichuriasis and Soil-Transmitted Helminthiases (STH) (4 arms), sponsored by Swiss Tropical and Public Health Institute. Primary endpoint: Egg reduction rate against Trichuris trichiura. Started Mar 2017; status: completed.
02
Drugs
moxidectintribendimidinealbendazoleoxantel
03
Conditions
trichuriasisSoil-Transmitted Helminthiases (STH)
Beyond the preview
Go deeper on ISRCTN20398469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN20398469.